In Stock, Ready to Ship!
Price range: $140.00 through $240.00 — or subscribe and save 20%
99% Pure | USA Made | Multi DoseSurvodutide is an investigational dual agonist peptide designed to mimic both GLP-1 (glucagon-like peptide-1) and glucagon signaling pathways, two key regulators of metabolic health. Currently in advanced research stages, Survodutide is being explored for its potential impact on appetite regulation, body weight reduction, hepatic fat loss, and insulin sensitivity. With emerging clinical data positioning it alongside or potentially beyond Tirzepatide in terms of body weight and fat mass modulation, Survodutide is rapidly gaining recognition as one of the most promising novel peptides in obesity and metabolic disorder research. Each research-grade vial of Survodutide from Real Peptides is produced in the USA, independently tested for 99%+ purity, and shipped with full transparency documentation—making it ideal for serious peptide investigators.
Peptides are not ready to use. Must purchase BAC water for reconstitution.
Survodutide is a novel dual agonist peptide under extensive scientific investigation for its effects on weight modulation and metabolic health. It functions by targeting both GLP-1 (glucagon-like peptide-1) and glucagon receptors, making it a next-generation compound in the GLP class of research peptides. Originally developed by Boehringer Ingelheim, Survodutide represents a hybrid molecule aiming to harness the benefits of incretin-based therapies and glucagon signaling to achieve superior metabolic outcomes.
In preclinical and early clinical studies, Survodutide has shown potential in reducing body weight, improving glucose regulation, and decreasing hepatic fat content. These mechanisms are similar to those of Tirzepatide, but with unique activity in fat oxidation and hepatic lipid metabolism.
Survodutide is gaining attention as a potent research compound in the realm of obesity, insulin resistance, and non-alcoholic fatty liver disease (NAFLD). Here are several reasons why scientists are incorporating Survodutide into their experimental protocols:
Survodutide differs from other GLP-1 class peptides by leveraging glucagon receptor activation to drive additional metabolic benefits. This dual-agonist mechanism introduces a more dynamic approach to energy regulation. Unlike Semaglutide or Tirzepatide, Survodutide offers:
In side-by-side comparison (Survodutide vs Tirzepatide), researchers are finding unique advantages in hepatic parameters, and Survodutide’s ability to elevate resting energy expenditure may complement other GLP analogues.
Real Peptides offers high-purity, U.S.-made Survodutide peptide with third-party testing and transparent lab reports included on every product page.
Don't hestitate to contact us
End of Content.
